|
|
.
See Category: Neoplasms
See Header: Multiple myeloma
ICD-10 (CM) Code and Descriptor
|
C90.02 |
Multiple myeloma in relapse
|
C9002 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 48.34%
|
33.31%
|
9.68%
|
3.27%
|
1.61%
|
1.27%
|
0.85%
|
0.50%
|
0.35%
|
0.25%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for C90.02*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
26,233
|
26,247
|
|
80053
|
COMPREHEN METABOLIC PANEL |
24,499
|
24,501
|
|
82784
|
ASSAY IGA/IGD/IGG/IGM EACH |
18,452
|
38,676
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
16,515
|
16,601
|
|
83883
|
ASSAY NEPHELOMETRY NOT SPEC |
15,957
|
22,567
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
14,516
|
14,558
|
|
84165
|
PROTEIN E-PHORESIS SERUM |
14,223
|
14,226
|
|
86334
|
IMMUNOFIX E-PHORESIS SERUM |
9,635
|
9,685
|
|
83615
|
LACTATE (LD) (LDH) ENZYME |
7,976
|
7,979
|
|
83735
|
ASSAY OF MAGNESIUM |
7,151
|
7,159
|
|
84100
|
ASSAY OF PHOSPHORUS |
6,079
|
6,083
|
|
96401
|
CHEMO ANTI-NEOPL SQ/IM |
5,958
|
6,463
|
|
83520
|
IMMUNOASSAY QUANT NOS NONAB |
5,619
|
8,098
|
|
96413
|
CHEMO IV INFUSION 1 HR |
5,381
|
5,382
|
|
J9047
|
INJECTION, CARFILZOMIB, 1 MG |
5,132
|
275,232
|
|
84550
|
ASSAY OF BLOOD/URIC ACID |
5,003
|
5,003
|
|
J9041
|
INJECTION, BORTEZOMIB, 0.1MG |
4,180
|
79,063
|
|
J9144
|
DARATUMUMAB, HYALURONIDASE |
4,029
|
712,503
|
|
96375
|
TX/PRO/DX INJ NEW DRUG ADDON |
4,002
|
6,163
|
|
36591
|
DRAW BLOOD OFF VENOUS DEVICE |
3,425
|
3,447
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
C90.02 related to the following DRG Codes:
820-822
823-825
840-842
|
